CD82通过改变脂质聚类和CD44内皮细胞贩运来抑制病态血管生成
Quan Wei1, Feng Zhang1, Mekel M Richardson1
1From the West China Hospital, Sichuan University, Chengdu, China (Q.W.); University of Oklahoma Health Science Center, Oklahoma City (Q.W., F.Z., M.M.R., W.R., Y.L., C.F., Y.D., C.H., L.D., Y.H., J.M., X.A.Z.); University of Vermont, Burlington (N.H.R., M.T.); University of Tennessee, Memphis (W.Z., Y.C., Y.S.); Tongji Hospital, Wuhan, China (Y.D., X.H.); Indiana University, Indianapolis (M.E.B.); Oklahoma Medical Research Foundation, Oklahoma City (S.P., J.D.W.); and German Cancer Research Center, Heidelberg, Germany (S.T., G.J.H.).
特拉斯巴宁CD82通过抑制内皮细胞运动来抑制病态血管生成. 它的缺失增强了细胞迁移和入侵,为血管生成相关疾病提供了潜在的治疗点.
科学领域:
- 血管生物学 血管生物学
- 细胞信号传输 细胞信号传输
- 分子医学是分子医学.
背景情况:
- 血管新生在癌症和炎症等疾病中至关重要.
- 血管生成的内皮细胞 (EC) 调节尚未完全理解.
- 拉斯巴宁CD82在EC的血管作用尚不清楚.
研究的目的:
- 研究CD82在血管生成中的功能.
- 确定CD82如何影响内皮细胞的行为.
- 探索CD82在病理性血管生成中的作用.
主要方法:
- 在Cd82-null小鼠中使用体内和体外试验检查了血管生成.
- 在Cd82-null ECs中分析了细胞功能,分子相互作用和信号.
- 评估了细胞粘附分子,脂质和内细胞分裂的变化.
主要成果:
- Cd82 除显著增加了血管新生反应.
- Cd82-null ECs显示移民和入侵的增加.
- 观察到高调的CD44和整体蛋白,增加的脂质聚类,以及改变的内细胞形成.
结论:
- CD82通过限制EC运动来抑制病态血管生成.
- 脂质集群和细胞粘附分子贩运调节血管生成潜力.
- 通过CD82-化物-CD44信号调制,可以减轻病理性血管生成.
更多相关视频
08:46Strategic Endothelial Cell Tube Formation Assay: Comparing Extracellular Matrix and Growth Factor Reduced Extracellular Matrix
Published on: August 14, 2016
09:03Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay
Published on: June 30, 2023
相关概念视频
Regulation of Angiogenesis and Blood Supply
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Inhibition of Cdk Activity
Mechanism of Angiogenesis
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
